Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30, 2026 along with Limited Review Report thereon